Showing results (181-190 of 197) with videos related to
Sort By:
Pageof 20
Cell Death and Differentiation|April 10, 2010
Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activationM Ehrenschwender, D Siegmund, A Wicovsky, et al.International Journal of Cancer|April 6, 2001
Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomasM Mersmann, A Schmidt, J F Rippmann, et al.The Journal of Biological Chemistry|May 16, 2000
The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activationF Mühlenbeck, P Schneider, J L Bodmer, et al.DNA and Cell Biology|December 1, 1990
Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding proteinA Himmler, I Maurer-Fogy, M Krönke, et al.Endocrinology|June 29, 1999
Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cellsL A Stephens, H E Thomas, L Ming, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophagesG Eissner, S Kirchner, H Lindner, et al.Blood|December 1, 1995
Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxinG Eissner, F Kohlhuber, M Grell, et al.Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|August 25, 2010
Growth of nanocrystals and thin films at the water-oil interfaceG L Stansfield, P V Vanitha, H M Johnston, et al.Cell Death and Differentiation|July 1, 1995
Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell deathM E Peter, S Hellbardt, R Schwartz-Albiez, et al.Cell Death & Disease|April 13, 2012
Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivityM Siegemund, N Pollak, O Seifert, et al.Pageof 20